<?xml version="1.0" encoding="UTF-8"?><!-- Converted from Majour with majour2a++ V1.11 --><!--Automatically converted from version 2.3 to 2.4-->

<!DOCTYPE Publisher
  PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>

   <PublisherInfo>

      <PublisherName>Springer-Verlag</PublisherName>

      <PublisherLocation>Berlin Heidelberg</PublisherLocation>

   </PublisherInfo>

   <Journal>

      <JournalInfo JournalProductType="Legacy" NumberingStyle="Unnumbered">

         <JournalID>105</JournalID>

         <JournalPrintISSN>0017-8470</JournalPrintISSN>

         <JournalSPIN/>

         <JournalTitle>Der Hautarzt</JournalTitle>

         <JournalSubTitle>Zeitschrift für Dermatologie, Allergologie, Venerologie und verwandte Gebiete</JournalSubTitle>

         <JournalAbbreviatedTitle>Hautarzt</JournalAbbreviatedTitle>
         <JournalSubjectGroup>
            <JournalSubject Type="Primary">Legacy</JournalSubject>
         </JournalSubjectGroup>

      </JournalInfo>

      <Volume>

         <VolumeInfo VolumeType="Regular">
            <VolumeIDStart>46</VolumeIDStart>
            <VolumeIDEnd>46</VolumeIDEnd>
            <VolumeIssueCount/>
         </VolumeInfo>

         <Issue IssueType="Regular">

            <IssueInfo TocLevels="0">

               <IssueIDStart>1</IssueIDStart>

               <IssueIDEnd>1</IssueIDEnd>

               <IssueHistory>

                  <PrintDate>

                     <Year>1995</Year>

                     <Month>1</Month>

                     <Day/>

                  </PrintDate>

                  <CoverDate>

                     <Year>1995</Year>

                     <Month>1</Month>

                  </CoverDate>

               </IssueHistory>

               <IssueCopyright>

                  <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>

                  <CopyrightYear>1995</CopyrightYear>

               </IssueCopyright>

            </IssueInfo>

            <Article ID="Art1">

               <ArticleInfo Language="En" ArticleType="OriginalPaper" NumberingStyle="Unnumbered" ContainsESM="No" TocLevels="0">

                  <ArticleID>50460004.105</ArticleID>

                  <ArticleDOI>10.1007/s001050050199</ArticleDOI>

                  <ArticleTitle Language="De">Moderne molekularbiologische Diagnostik kutaner maligner Lymphome</ArticleTitle>

                  <ArticleTitle Language="En">New molecular biology aspects in the diagnosis of cutaneous malignant lymphoma</ArticleTitle>

                  <ArticleCategory/>

                  <ArticleFirstPage>4</ArticleFirstPage>

                  <ArticleLastPage>9</ArticleLastPage>

                  <ArticleCopyright>

                     <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>

                     <CopyrightYear>1995</CopyrightYear>

                  </ArticleCopyright>
                  <ArticleGrants>
                     <MetadataGrant Grant="OpenAccess"/>
                     <AbstractGrant Grant="OpenAccess"/>
                     <BodyPDFGrant Grant="Restricted"/>
                     <BodyHTMLGrant Grant="Restricted"/>
                     <BibliographyGrant Grant="Restricted"/>
                     <ESMGrant Grant="Restricted"/>
                  </ArticleGrants>

               </ArticleInfo>

               <ArticleHeader>

                  <AuthorGroup>

                     <Author AffiliationIDS="A1">

                        <AuthorName DisplayOrder="Western">

                           <GivenName>Wolfram</GivenName>

                           <FamilyName>Sterry</FamilyName>

                        </AuthorName>

                     </Author>

                     <Author AffiliationIDS="A1">

                        <AuthorName DisplayOrder="Western">

                           <GivenName>Gyde</GivenName>

                           <FamilyName>Staib</FamilyName>

                        </AuthorName>

                     </Author>

                     <Affiliation ID="A1">

                        <OrgName>Abteilung Dermatologie (Ärztl. Direktor: Prof. Dr. W. Sterry), Universität, Ulm</OrgName>

                        <OrgAddress>

                           <Street/>

                           <Postbox/>

                           <Postcode/>

                           <City/>

                           <State/>

                           <Country>DE</Country>

                        </OrgAddress>

                     </Affiliation>

                  </AuthorGroup>

                  <Abstract ID="Abs1" Language="De">

                     <Heading>Zusammenfassung.</Heading>

                     <Para> Die Diagnosestellung primär kutaner maligner Lymphome stützt sich neben den klinischen, histomorphologischen und immunhistochemischen Befunden seit jüngster Zeit auch auf molekularbiologische Analysen des Genotyps eines Lymphominfiltrates. Dabei wird mit Hilfe der Polymerase-Ketten-Reaktion (PCR) linienspezifisch für die Immunglobulin- oder T-Zell-Rezeptorgene eine monoklonale maligne Zellpopulation im Infiltrat nachgewiesen. Dieses Verfahren ist innerhalb von 3 Tagen an kleinen, paraffingebetteten Haut- und Lymphknotenbiopsaten sowie herparinisiertem Blut der Patienten durchführbar, erfordert keine Radioaktivität und weist deshalb gegenüber herkömmlichen Techniken, z. B. dem Southern-Blot deutliche Vorteile auf. Desweiteren wäre durch derartige PCR-Analysen ein patientenspezifisches Monitoring unter einer entsprechenden Therapie möglich, das frühzeitig ein Rezidiv der malignen lymphoproliferativen Erkrankung aufzeigen könnte.</Para>

                  </Abstract>

                  <Abstract ID="Abs2" Language="En">

                     <Heading>Abstract.</Heading>

                     <Para> The diagnosis of cutaneous malignant lymphoma is based on clinical, histo-morphological and immunochemical findings and, nowadays, on molecular biology analyses of the genotyp in the lymphocytic infiltrate. By using the polymerase chain reaction (PCR) with specific primers for the Ig heavy chain gene and the T-cell receptor gamma chain gene, the detection of monoclonal cell populations in the skin infiltrate is possible. Since this method produces results within 3 days, since paraffin-embedded skin and lymph node biopsies and heparinized peripheral blood can be used and since no radioactivity is necessary, this technique has important advantages over traditional techniques such as Southern blot analyses. In addition, specific PCR analyses may allow a patient-specific monitoring during therapy and also may detect early relapses of the lymphoproliferative malignant disease.</Para>

                  </Abstract>

                  <KeywordGroup Language="En">

                     <Keyword>Schlüsselwörter: Kutane maligne Lymphome – Diagnostik – PCR-Analysen – Patientenmonitoring</Keyword>

                  </KeywordGroup>

                  <KeywordGroup Language="En">

                     <Keyword>Key words: Cutaneous malignant lymphoma – Early diagnosis – PCR analyses – Patient monitoring</Keyword>

                  </KeywordGroup>

                  <ArticleNote Type="Misc">

                     <SimplePara>Eingegangen am 1. Februar 1994 / Angenommen am 10. Februar 1994</SimplePara>

                  </ArticleNote>

               </ArticleHeader>

               <NoBody/>

            </Article>

         </Issue>

      </Volume>

   </Journal>

</Publisher>